Trial Profile
Phase 1 drug-drug interaction study of HL-008 XC Hybrid Combination product
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Amlodipine/losartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors HanAll Biopharma
- 14 Mar 2016 New trial record